OSELTAMIVIR PHOSPHATE
NDC 69315-174, OSELTAMIVIR PHOSPHATE, suspension, from Leading Pharma, LLC.
- Product NDC
- 69315-174
- Status
- Listed
- Labeler
- Leading Pharma, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214949
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69315-174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OSELTAMIVIR PHOSPHATE6 mg/mL
Pharmacologic classes
Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69315-174-60 | 69315017460 | 60 mL in 1 BOTTLE (69315-174-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ef093e4d-5b1a-463f-a1a3-b795a4387a81
Use it
Look up 69315-174 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69315-174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69315-174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.